CDC recommend Artesunate as First-Line Treatment for Severe Malaria in US
CDC recommend Artesunate as First-Line Treatment for Severe Malaria in US CDC is issuing new guidance to clinicians recommending Artesunate,WHO-recommended first-line treatment of severe malaria,as First-Line Treatment for Severe Malaria since April 2019.
CDC is issuing new guidance to clinicians recommending Artesunate as First-Line Treatment for Severe Malaria in the United States of America(U.S.A). This change in treatment protocol is necessary because the only FDA-approved intravenous (IV) antimalarial drug in the U.S., quinidine, has been discontinued by the manufacturer and will no longer be available.
As of April 2019, artesunate,…
View On WordPress















